Academic Journal
Q1NAR Cancer
About NAR Cancer
NAR Cancer is a scholarly journal published by Oxford University Press. SCImago 2025 lists it in Q1, with an SJR of 2.019 and H-index of 30.
Coverage: 2019-2026. Research categories: Cancer Research (Q1); Oncology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-03. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
DNA Repair Mechanisms; RNA modifications and cancer; Cancer Genomics and Diagnostics; RNA Research and Splicing; PARP inhibition in cancer therapy; Epigenetics and DNA Methylation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
N 6-methyladenosine promotes temozolomide resistance through mRNA stabilization in glioblastoma cells
Emily A Dangelmaier, Dorthy Fang, Isabel P Hardy, Kyal Sin Htet et al.
2026-09-30 · DOI: 10.1093/narcan/zcag027RAD51C breast cancer-identified variants with attenuated homologous recombination function exhibit sensitivity to combined PARP1 and ATR inhibition
Gayatri S Ganesan, Zoë R Moosbrugger, Phoebe S Parker, Noah J Goff et al.
2026-07-27 · DOI: 10.1093/narcan/zcag018Beyond the canonical view: steroid receptor network plasticity and mechanosensitive chromatin integration in breast cancer
Judith García-García, Rosario Sanz Pérez, A Silvina Nacht, Diego M Presman et al.
2026-07-27 · DOI: 10.1093/narcan/zcag016IGF2BP3 remodels RISC occupancy to control microRNA targeting in leukemia
Lyna E S Kabbani, Shruti Kapoor, Gunjan Sharma, Martin Gutierrez et al.
2026-07-27 · DOI: 10.1093/narcan/zcag025A complex mutational signature generated by cytarabine resistance
Dengchao Cao, Mianmian Yin, Ryan Bertoli, Zhenhua Zhang et al.
2026-07-27 · DOI: 10.1093/narcan/zcag017STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation
Zubair Ahmed Laghari, Na Li, Serdar Gayybov, Qi-En Wang et al.
2026-07-27 · DOI: 10.1093/narcan/zcag023Cross-modal mapping of cancer stem-like cell plasticity using deep learning
Debojyoti Chowdhury, Shreyansh Priyadarshi, Sayan Biswas, Bhavesh Neekhra et al.
2026-07-27 · DOI: 10.1093/narcan/zcag015Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer
Junhuan Xia, Jingwen Tian, Yuting Cao, Suhan Zhang et al.
2026-07-27 · DOI: 10.1093/narcan/zcag026Motif-centered analyses reveal universal and tissue-specific mutagenic mechanisms operating in the human body
Safia Mahabub Sauty, Yun-Chung Hsiao, Leszek J Klimczak, Dmitry A Gordenin et al.
2026-07-27 · DOI: 10.1093/narcan/zcag024Multi-omic cell free DNA profiles of cerebral spinal fluid from lung cancer metastasis to the brain
Tianqi Chen, Xiangqi Bai, Georgiana Burnside, Thy Trang Hoang Trinh et al.
2026-07-27 · DOI: 10.1093/narcan/zcag021SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications
Marcela Briones-Martin-del-Campo, Alex G Lee, Truc Dinh, Virginie Marchand et al.
2026-07-27 · DOI: 10.1093/narcan/zcag019LncRNA RAMS11 -dependent NOTCH3 activation drives tumor progression in non-small cell lung cancer
Gejae G Jeffers, Yesol Kim, Nicole M White, Li Lin et al.
2026-07-27 · DOI: 10.1093/narcan/zcag020In vivo selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model
Caroline D Doherty, Sonia Jain, Lauren L Ott, Katie K Bakken et al.
2026-07-27 · DOI: 10.1093/narcan/zcag022Uncovering novel germline variants associated with testicular germ cell tumors by exome sequencing
Berenice Cuevas-Estrada, Juan A Ríos-Rodríguez, José A García-Pacheco, Talia Wegman-Ostrosky et al.
2026-04-08 · DOI: 10.1093/narcan/zcag007Efficient gene disruption with CRISPR–Cas3 in human T cells
Tomoaki Fujii, Yukimi Sakoda, Kazuto Yoshimi, Kohei Takeshita et al.
2026-04-08 · DOI: 10.1093/narcan/zcag009Sensitive detection of somatic mutations in GC-rich cancer gene promoters
Meifang Qi, Preshita Sanjay Dave, Nicole Francis, Matthew DeFelice et al.
2026-04-08 · DOI: 10.1093/narcan/zcag011Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer
Lee J Pribyl, Jennifer E Kay, Joshua J Corrigan, Lindsay B Volk et al.
2026-04-08 · DOI: 10.1093/narcan/zcag014Loss of CHTF18–RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors
Lauryn Buckley-Benbow, Meryem Ozgencil, Alessia Tardocchi, Alessandro Agnarelli et al.
2026-04-08 · DOI: 10.1093/narcan/zcag013MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription
Reshma Kalyan Sundaram, Kshitiz Parihar, Stephanie Monson, Ravi Radhakrishnan et al.
2026-04-08 · DOI: 10.1093/narcan/zcag010Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis
Thi Tran, Jiayi Fan, Xiaolan Zhao, Abby M Green et al.
2026-04-08 · DOI: 10.1093/narcan/zcag012Reviews
Community Reviews
Version History
October 4, 2026 at 8:47 pm
September 25, 2026